BIIB
$154.32
Revenue | $2534.7Mn |
Net Profits | $466.5Mn |
Net Profit Margins | 18.4% |
Biogen Inc.’s revenue jumped 2.79% since last year same period to $2534.7Mn in the Q3 2025. On a quarterly growth basis, Biogen Inc. has generated -4.19% fall in its revenue since last 3-months.
Biogen Inc.’s net profit jumped 20.08% since last year same period to $466.5Mn in the Q3 2025. On a quarterly growth basis, Biogen Inc. has generated -26.51% fall in its net profits since last 3-months.
Biogen Inc.’s net profit margin jumped 16.81% since last year same period to 18.4% in the Q3 2025. On a quarterly growth basis, Biogen Inc. has generated -23.3% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 3.85 |
EPS Estimate Current Year | 3.85 |
Biogen Inc.’s earning per share (EPS) estimates for the current quarter stand at 3.85 - a -0.77% fall from last quarter’s estimates.
Biogen Inc.’s earning per share (EPS) estimates for the current year stand at 3.85.
Earning Per Share (EPS) | 0 |
Biogen Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Biogen Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-01 | 2.95 | 3.02 | 2.37% |
2025-07-31 | 3.88 | 5.47 | 40.98% |
2025-10-30 | 3.85 | 0 | -100% |